about
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastEvaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis.Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid.Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic modelThe conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspectiveIntra-cavitary pulmonary cryptococcoma in poorly controlled diabetes mellitusPerformance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patientsTuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of DeathAlgorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow deviceBurden of fungal asthma in Africa: A systematic review and meta-analysisCor pulmonale complicating chronic pulmonary aspergillosis with fatal consequences: Experience from UgandaMinimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelManagement of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort studyGetting Histoplasmosis on the Map of International Recommendations for Patients with Advanced HIV DiseaseMycetoma in Uganda: A neglected tropical diseaseChronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist
P50
Q24620256-CE478793-C37E-4B73-866C-E97FE4D1FBA0Q35855950-C6E92751-63D6-4DBA-9066-4014ECEA3624Q38602639-109B8FE7-7076-451F-B286-8A957A7F624CQ38849132-8FDECDA6-0F4E-40F4-9EC7-5C38D71B4251Q38849478-F2798591-58BE-4123-906A-6BF0766F2F8AQ47102823-18823CB6-E40B-4E85-93B1-5C3D3DB6BE8EQ50053465-FB7DBAC0-845D-48AF-9813-92A188BBE239Q56837217-6FF178DE-D51B-49CD-9E6F-15505D0CB4F5Q63379730-57ACA2FC-377A-4BB1-A24F-F00D34914DFDQ90179103-A1EBEA66-0781-4589-BE86-69C266C4A69BQ90207549-65BC72E8-1403-4B9B-82F5-3D0D9438F9F8Q90397541-EA3A50CF-0620-489A-B870-E83D4CAC7EA1Q91770287-4F717DAA-FFF3-40AD-95E7-B8FB65BED17AQ92075384-C5EDCA53-D06B-4079-91CC-E63197940278Q92109442-A7B84777-7910-41A6-B70C-D3F79DA1AFC2Q92669284-726C6A97-786B-448A-B401-9EC6720240DEQ93050183-6F7CB892-1CFD-466F-B8E6-50E637D22CB1Q93081589-9417BDDB-4BC3-4929-B1F3-F5DC175437EDQ94457560-3B0A94CB-8247-4438-BE77-7AAC201B4B10Q96129117-4DDB788D-8378-4B30-9587-CEC87D97BC60
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard Kwizera
@ast
Richard Kwizera
@en
Richard Kwizera
@es
Richard Kwizera
@nl
type
label
Richard Kwizera
@ast
Richard Kwizera
@en
Richard Kwizera
@es
Richard Kwizera
@nl
prefLabel
Richard Kwizera
@ast
Richard Kwizera
@en
Richard Kwizera
@es
Richard Kwizera
@nl
P106
P21
P31
P496
0000-0002-5270-3539